BUENA, N.J., Jan. 8, 2015 /PRNewswire/ -- IGI
Laboratories, Inc. (NYSE Amex: IG), a New
Jersey based specialty generic pharmaceutical company, will
be presenting at the 33RD Annual J.P. Morgan Healthcare
Conference. The Conference will take place on January 12-15, 2015 at the Westin St. Francis
Hotel in San Francisco,
California.
Jason Grenfell-Gardner, CEO and
President and Jenniffer Collins,
Chief Financial Officer of IGI Laboratories, Inc. will present on
Thursday January 15,
2015 at 10:30 a.m. PT.
The presentation will be webcast and will be accessible online
on the investors section of the Company's website at
http://www.igilabs.com. A replay will be available for 90 days.
About IGI Laboratories, Inc.
IGI Laboratories is a
specialty generic drug development and manufacturing company. Our
mission is to be a leading player in the specialty generic
prescription drug market.
Logo -
http://photos.prnewswire.com/prnh/20130827/MM70487LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/igi-laboratories-to-present-at-33rd-annual-jp-morgan-healthcare-conference-on-january-15-2015-300017530.html
SOURCE IGI Laboratories, Inc.